During the past decade, VA Connecticut Healthcare System West Haven Campus, West Haven, CT conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 64 clinical trials were completed, i.e. on average, 59.8% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 34 clinical trials were completed. i.e. 82.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" #1 sponsor was "VA Office of Research and Development" with 71 trials, followed by "Yale University" with 45 trials sponsored, "US Department of Veterans Affairs" with 32 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored and "National Cancer Institute (NCI)" with 19 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 15 trials as a collaborator, "US Department of Veterans Affairs" with 11 trials as a collaborator, "Yale University" with 9 trials as a collaborator and "VA Connecticut Healthcare System" with 8 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" are "Nicotine Dependence" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Pain" (6 trials). Many other conditions were trialed in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" in a lesser frequency.

Most popular intervention types in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" are "Drug" (117 trials), "Behavioral" (60 trials), "Other" (46 trials), "Procedure" (24 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Laboratory Biomarker Analysis" (12 trials), "Docetaxel" (10 trials), "Nivolumab" (9 trials) and "Biospecimen Collection" (8 trials). Other intervention names were less common.

The vast majority of trials in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT" are 201 trials for "All" genders, 9 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are 73 active trials in "VA Connecticut Healthcare System West Haven Campus, West Haven, CT". 5 are not yet recruiting, 38 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 128 completed trials in VA Connecticut Healthcare System West Haven Campus, West Haven, CT, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in VA Connecticut Healthcare System West Haven Campus, West Haven, CT, 23 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 76 trials that are defined as “Not Applicable".